Regeneron Targets Vulnerable Populations In COVID-19 Pact With BARDA

 
• By Alaric DeArment

The company is developing a next-generation antibody for prevention of COVID-19 that targets highly conserved regions of the SARS-CoV-2 virus and thus may be able to overcome resistance.

Regeneron is partnering with BARDA to develop a next-generation COVID-19 antibody • Source: Shutterstock

More from COVID-19

More from Scrip